Dr. Callisia N. Clarke, MD

  • Milwaukee, WI
  • Surgical oncologist
NPI1275752578PAC ID4789823212
Medicare services, 2024
69
Medicare patients, 2024
71
Part D claims, 2017
11
Publications
71
MIPS score, 2024
88
Practice address
9200 W Wisconsin Ave, Milwaukee, WI 53226
Practice phone
Call (414) 805-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Froedtert Hospital

Hospital · Milwaukee, Wisconsin

See all 3 affiliations

Find Dr. Clarke's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Callisia N. Clarke is a surgical oncologist in Milwaukee, Wisconsin

Dr. Clarke practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Clarke's NPI, 1275752578, was assigned on April 25, 2007. Dr. Clarke graduated from University of Cincinnati College of Medicine in 2006. Dr. Clarke holds Wisconsin license 66205.

NPI and contact details
Medicare PAC ID
4789823212
NPI enumeration date
April 25, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(414) 805-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
46
Medical school graduation
2006

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Callisia N. Clarke practices at Froedtert Hospital in Milwaukee, Wisconsin

Dr. Clarke's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

  • Froedtert Hospital
    9200 W Wisconsin Ave, Milwaukee, WI 53226 · Milwaukee CountyPhone(414) 805-3000

Source: Dmand AI Affiliation Data

Dr. Callisia N. Clarke is affiliated with 2 sites of care and 1 medical group

Dr. Clarke's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Clarke to 1 more home health agency, named with a free account.

See all 3 affiliations for Dr. Clarke

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Callisia N. Clarke's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clarke practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Froedtert HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Clarke practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Froedtert ThedaCare Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Callisia N. Clarke is one of 33 surgical oncologists in Wisconsin

Surgical oncology is Dr. Clarke's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Clarke's licenses on file in 3 states: Wisconsin, Ohio and Texas.

Specialties and state licenses

  • Surgical oncology, WisconsinPrimaryLicense 66205 · taxonomy 2086X0206X
  • Ohio licenseLicense 57012026
  • Surgery, TexasLicense P5611 · taxonomy 208600000X

Surgical oncologists near Dr. Clarke

Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Callisia N. Clarke billed Medicare for 69 services in 2024

CMS data shows 69 Medicare services from Dr. Clarke across 3 procedure codes in 2024, all of them office visits, for 71 Medicare patients. Medicare paid $7,348 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 202469
Medicare patients71
Paid by Medicare$7,348
Procedure codes3

Dr. Clarke's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 142024: 69393%

Dr. Clarke compared with the Wisconsin median for surgical oncologists, 2024

  • Dr. Clarke
  • Wisconsin median
Medicare services
69vs 9124% below
Medicare patients
71vs 71Close to median
Part D claims
11vs 1631% below

Medians across 29 surgical oncologists in Wisconsin with Dmand AI profiles that report each measure.

Dr. Clarke's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Clarke

Need commercial claims for Dr. Clarke?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Clarke and other surgical oncologists in Wisconsin.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Callisia N. Clarke treated 71 Medicare patients in 2024, average age 74

CMS counts 71 Medicare patients who saw Dr. Clarke in 2024. The largest group is 65 to 74, with 38 patients. 70% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clarke's median patient age at 66, with 54% women.

Medicare patients, 202471
Average age74
Average risk score1.67

Dr. Clarke's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Clarke's Medicare patients by sex, 2024

  • Women4361%
  • Men2839%

Chronic conditions among Dr. Clarke's Medicare patients, 2024

  1. High cholesterol70%
  2. High blood pressure65%
  3. Arthritis38%
  4. Mood disorders38%
  5. Depression35%
  6. Anxiety34%
  7. Diabetes32%
  8. Chronic kidney disease27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Clarke's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women54%
  • Men46%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Callisia N. Clarke wrote 11 Medicare Part D claims in 2017

In 2017, Dr. Clarke wrote 11 Medicare Part D claims. They cover 1 drug, with $3,832 in total drug cost.

Part D claims, 201711
Drugs named by CMS1
Total drug cost$3,832

Dr. Clarke's most prescribed drugs by claims, 2017

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

See all prescribing by Dr. Clarke

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

Dr. Callisia N. Clarke scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Clarke for performance year 2024, reported as part of a group. Dr. Clarke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clarke as offering telehealth. CMS counts 22 procedures of melanoma (skin cancer) excision by Dr. Clarke, more than 76% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Clarke's MIPS scores, performance year 2024

  • 88of 100Final score
  • 82.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 77of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Where Dr. Clarke ranks in Medicare procedure volume

Melanoma (skin cancer) excision
76th percentile22 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find surgical oncologists like Dr. Clarke by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Callisia N. Clarke has 71 publications on record

Dmand AI links 71 papers to Dr. Clarke, published from 2017 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy and Antineoplastic Combined Chemotherapy Protocols. Dr. Clarke has published most often in Ann Surg Oncol. Dr. Clarke's most frequent co-authors are Jordan M. Cloyd, MD, Keith Francis Fournier, MD and Daniel Erik Abbott, MD.

Papers71
Years published2017 to 2025

Dr. Clarke's papers by year, 2017 to 2025

Topics Dr. Clarke writes about most

  • Cytoreduction Surgical Procedures
  • Hyperthermic Intraperitoneal Chemotherapy
  • Antineoplastic Combined Chemotherapy Protocols
  • Pancreatic Neoplasms
  • Hyperthermia, Induced
  • Neuroendocrine Tumors
  • Colorectal Neoplasms
  • Peritoneal Neoplasms

Dr. Clarke's most frequent co-authors

Recent publications by Dr. Clarke

See all 71 publications and co-authors

See who Dr. Clarke researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Clarke works with, so you can find a warm path to the right surgical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Callisia N. Clarke received $15,773 in industry payments from 2018 to 2025

CMS Open Payments shows 22 general payments to Dr. Clarke from 11 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $14,906.

General payments to Dr. Clarke by program year, 2018 to 2025

General payments to Dr. Clarke by kind, 2018 to 2025

$15.8Kin total
  • Speaker and faculty fees$12,74081%
  • Food and beverage$1,70011%
  • Travel and lodging$1,3338%

Companies that paid Dr. Clarke the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Clarke

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Callisia N. Clarke graduated from University of Cincinnati College of Medicine

Dr. Clarke graduated from University of Cincinnati College of Medicine in 2006.

  1. Medical schoolUniversity of Cincinnati College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Callisia N. Clarke's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Callisia N. Clarke

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Callisia N. Clarke's NPI number?

Dr. Callisia N. Clarke's NPI number is 1275752578. It was assigned on April 25, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Callisia N. Clarke?

Dr. Callisia N. Clarke is a surgical oncologist in Milwaukee, Wisconsin. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).

Where does Dr. Callisia N. Clarke practice?

Dr. Clarke practices at 9200 W Wisconsin Ave, Milwaukee, WI 53226. Dr. Clarke's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dmand AI also links Dr. Clarke to 1 home health agency.

What is Dr. Callisia N. Clarke's office phone number?

The practice phone on file for Dr. Clarke is (414) 805-3000.

What is Dr. Callisia N. Clarke's medical license number?

Dr. Clarke holds Wisconsin license 66205, one of the licenses on file in 3 states.

Which states has Dr. Callisia N. Clarke been licensed in?

Dmand AI has state licenses on file for Dr. Clarke in Wisconsin, Ohio and Texas.

Which hospitals is Dr. Callisia N. Clarke affiliated with?

Dr. Clarke practices at Froedtert Hospital in Milwaukee, Wisconsin.

What medical group is Dr. Callisia N. Clarke part of?

Dr. Clarke is linked to Froedtert & the Medical College of Wisconsin Community Physicians.

Does Dr. Callisia N. Clarke accept Medicare?

Yes. CMS data shows Dr. Clarke billed Medicare for 69 services in 2024, and Dr. Clarke accepts Medicare assignment.

Does Dr. Callisia N. Clarke offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Clarke as offering telehealth services.

Show 9 more questionsShow fewer questions

What is Dr. Callisia N. Clarke's MIPS score?

Dr. Clarke's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

How many Medicare patients does Dr. Callisia N. Clarke see?

CMS counts 71 Medicare patients who saw Dr. Clarke in 2024, with an average age of 74.

What services does Dr. Callisia N. Clarke bill to Medicare?

In 2024, Dr. Clarke's most billed Medicare services were office visit, new patient (99205), office visit, established patient (99214) and office visit, established patient (99215).

Where did Dr. Callisia N. Clarke go to medical school?

Dr. Clarke graduated from University of Cincinnati College of Medicine in 2006.

What drugs does Dr. Callisia N. Clarke prescribe most?

In 2017 Medicare Part D data, Dr. Clarke's most prescribed drugs by claims were Creon.

Has Dr. Callisia N. Clarke received payments from drug or device companies?

CMS Open Payments shows $15,773 in general payments to Dr. Clarke from 11 companies from 2018 to 2025. The largest total came from Ipsen Biopharmaceuticals, Inc.

How long has Dr. Callisia N. Clarke been practicing?

Dr. Clarke graduated from medical school in 2006, 20 years ago.

Does Dr. Callisia N. Clarke do research?

Dmand AI links 71 publications to Dr. Clarke, published from 2017 to 2025.

Who does Dr. Callisia N. Clarke publish with?

Dr. Clarke's most frequent co-authors are Jordan M. Cloyd, MD (19 shared papers), Keith Francis Fournier, MD (18 shared papers) and Daniel Erik Abbott, MD (17 shared papers).

Selling to surgical oncology practices?

See surgical oncologists in Wisconsin by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)